Brief: Anika Therapeutics Q4 Revenue USD 30.602 Million
12/03/2025 20:06
Mar 12 (Reuters) - Anika Therapeutics Q4 net income USD -21.865 million. Q4 pretax profit USD 38 thousand Q4 gross profit USD 17.125 million
Recent news on Anika Therapeutics
See all newsAnika Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Anika Therapeutics Q2 revenue rises, lifts 2026 outlook
Anika Therapeutics Inc expected to post a loss of 8 cents a share - Earnings Preview
Brief: Anika Therapeutics Enters Fifth Amendment To Credit Agreement - SEC Filing
Anika Therapeutics Q1 revenue rises 13%